“Humanized” Stem Cell Culture Techniques : The Animal Serum Controversy

Cellular therapy is reaching a pinnacle with an understanding of the potential of human mesenchymal stem cells (hMSCs) to regenerate damaged tissue in the body. The limited numbers of these hMSCs in currently identified sources, like bone marrow, adipose tissue, and so forth, bring forth the need fo...

Full description

Saved in:
Bibliographic Details
Published inStem cells international Vol. 2011; no. 2011; pp. 1 - 14
Main Authors Tekkatte, Chandana, Gunasingh, Gency Ponrose, Cherian, K. M., Sankaranarayanan, Kavitha
Format Journal Article
LanguageEnglish
Published Cairo, Egypt Hindawi Puplishing Corporation 01.01.2011
SAGE-Hindawi Access to Research
Hindawi Limited
Wiley
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Cellular therapy is reaching a pinnacle with an understanding of the potential of human mesenchymal stem cells (hMSCs) to regenerate damaged tissue in the body. The limited numbers of these hMSCs in currently identified sources, like bone marrow, adipose tissue, and so forth, bring forth the need for their in vitro culture/expansion. However, the extensive usage of supplements containing xenogeneic components in the expansion-media might pose a risk to the post-transplantation safety of patients. This warrants the necessity to identify and develop chemically defined or “humanized” supplements which would make in vitro cultured/processed cells relatively safer for transplantation in regenerative medicine. In this paper, we outline the various caveats associated with conventionally used supplements of xenogenic origin and also portray the possible alternatives/additives which could one day herald the dawn of a new era in the translation of in vitro cultured cells to therapeutic interventions.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Academic Editor: B. Bunnell
ISSN:1687-966X
1687-9678
1687-9678
DOI:10.4061/2011/504723